MedPath

Assessment of Symptoms and Consequences of Coloanal Continuity Reconstruction

Not Applicable
Completed
Conditions
Rectal Cancer
Interventions
Procedure: Pre- and post-operative consultation
Procedure: Stomatherapy consultation
Procedure: Questionnaires
Registration Number
NCT03292289
Lead Sponsor
Centre Oscar Lambret
Brief Summary

This study is a prospective, monocentric study whose aim is to assess the quality of life for patients who underwent a coloanal continuity reconstruction and to understand the functional issues they encounter. This will potentially provide predictive factors identification of bad functional outcomes allowing to guide future decisions. Also, it will allow patients to have a reinforced follow-up during the year after the reconstruction.

Detailed Description

First of all, an information document will be given to the patients and their consent will be collected. Then, they will be registered through the online eCRF (or by FAX) and a study number will be given to each patient.

The study will proceed with 2 stomatherapy consultations at one and six months after coloanal continuity reconstruction. Patient care and following up will proceed as usual. The stomatherapy consultation will be done by a qualified nurse.

Before the 1st intervention (proctectomy):

* Collect of clinical data and disease history

* Quality of life questionnaires (EORTC-QLQ-C30 and CR29)

* Evaluation of LARS score

After the 1st intervention (proctectomy, at month 1):

- Quality of life : EORTC-QLC30 and CR-29 questionnaires and Stom-QoL

Before the 2nd intervention (coloanal continuity reconstruction):

- Quality of life : EORTC-QLC30 and CR-29 questionnaires and Stom-QoL

After the 2nd intervention (at month 1, month 3, month 6 and one year):

* at 1 and 6 months : clinical exam (stomatherapy consultation) for collect of postoperative complications

* Quality of life : EORTC-QLC30 and CR-29 questionnaires and LARS score

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
65
Inclusion Criteria
  • 18 to 70 years old
  • Patients who are going to undergo a proctectomy for a rectal cancer (situated at a distance equal or lower to 15 cm from the anoderm) following by a coloanal continuity reconstruction (using direct, latero-terminal or colonic J-pouch anastomosis)
  • Already underwent or not a neoadjuvant radio-chemotherapy
  • Affiliation to the National Social Security System
  • With informed and signed consent
Exclusion Criteria
  • Unwilling patients
  • Patient deprived of their liberty or under guardianship or tutorship.
  • Abdominal perineal amputation
  • No stoma placement planned
  • Tumor more than 15 cm from the anal margin

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Study processQuestionnairesPre- and post-operative consultations. Stomatherapy consultation. Questionnaires
Study processStomatherapy consultationPre- and post-operative consultations. Stomatherapy consultation. Questionnaires
Study processPre- and post-operative consultationPre- and post-operative consultations. Stomatherapy consultation. Questionnaires
Primary Outcome Measures
NameTimeMethod
Quality of life 1 year after the second intervention, using LARS scorefrom baseline to 1 year after the second intervention

Obtain an objective assessment of symptoms intensity (using the LARS score)for patients who received a proctectomy for rectal cancer ("1st intervention") following by a coloanal continuity reconstruction ("2nd intervention")

Secondary Outcome Measures
NameTimeMethod
Quality of life using EORTC-QLQ-C30from baseline to one year after the 2nd intervention

Assess the quality of life using EORTC-QLQ-C30 questionnaires before the first intervention, between the first and the second intervention and after the second intervention

Surgical complications descriptionfrom first intervention to one year after the 2nd intervention

Describe surgical complications linked to the coloanal continuity reconstruction

Quality of life of patients with a second stoma placement, using EORTC-QLQ-CR29 questionnairesFrom the 2nd intervention to one year after the 2nd intervention

Assess the quality of life of patients who have a new stoma for functional disorder after restoration of digestive continuity .

Quality of life using EORTC-QLQ-CR29 questionnairesfrom baseline to one year after the 2nd intervention

Assess the quality of life using EORTC-QLQ- CR29 questionnaires before the first intervention, between the first and the second intervention and after the second intervention

Quality of life before the first intervention and after the second interventionfrom baseline to one year after the 2nd intervention

Obtain an objective assessment of symptoms intensity (using the LARS score)for patients who received a proctectomy for rectal cancer ("1st intervention") following by a coloanal continuity reconstruction ("2nd intervention")

Rate of patients with anastomotic fistulafrom the first intervention to 6 months after the first intervention

Determinate the rate of patients with anastomotic fistula requiring the conservation of the stomy, and so they cannot undergo a coloanal continuity reconstruction

Quality of life of patients with a second stoma placement, using EORTC-QLQ-C30 questionnairesFrom the 2nd intervention to one year after the 2nd intervention

Assess the quality of life of patients who have a new stoma for functional disorder after restoration of digestive continuity .

Impact of stomy on quality of lifefrom the first intervention to 6 months after the first intervention

Assess the impact of stomy on quality of life for patients who received a proctectomy for rectal cancer and using Stoma-QoL questionnaire

Quality of life of patients with a second stoma placement, using LARS scoreFrom the 2nd intervention to one year after the 2nd intervention

Assess the quality of life of patients who have a new stoma for functional disorder after restoration of digestive continuity .

Trial Locations

Locations (1)

Centre Oscar Lambret

🇫🇷

Lille, France

© Copyright 2025. All Rights Reserved by MedPath